Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Cash Flow Statement
Cash Flow Statement
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|
Operating Cash Flow | ||||
Net Income |
(890)
|
(567)
|
(468)
|
|
Depreciation & Amortization |
23
|
67
|
75
|
|
Other Non-Cash Items |
102
|
195
|
177
|
|
Cash Interest Paid |
40
|
3
|
10
|
|
Change in Working Capital |
279
|
35
|
276
|
|
Cash from Operating Activities |
(486)
N/A
|
(271)
+44%
|
60
N/A
|
|
Investing Cash Flow | ||||
Capital Expenditures |
(95)
|
(39)
|
(82)
|
|
Other Items |
0
|
7
|
(943)
|
|
Cash from Investing Activities |
(94)
N/A
|
(32)
+66%
|
(1 025)
-3 089%
|
|
Financing Cash Flow | ||||
Net Issuance of Common Stock |
534
|
0
|
2 853
|
|
Net Issuance of Debt |
153
|
316
|
(461)
|
|
Other |
(40)
|
(3)
|
(10)
|
|
Cash from Financing Activities |
647
N/A
|
313
-52%
|
2 382
+660%
|
|
Change in Cash | ||||
Effect of Foreign Exchange Rates |
(1)
|
1
|
19
|
|
Net Change in Cash |
66
N/A
|
11
-83%
|
1 436
+12 758%
|
|
Free Cash Flow | ||||
Free Cash Flow |
(581)
N/A
|
(310)
+47%
|
(23)
+93%
|